How to Beat Copay Accumulators and Maximizers in 2026: The State-by-State Guide to Getting Manufacturer Assistance to Count Toward Your Deductible

You pick up your specialty prescription in January. The pharmacist runs your manufacturer copay card and hands you a bag with a $0 receipt. Great. Then in April, you pick up your second refill and the pharmacist quietly says, "That'll be $1,847." The card is exhausted, the drug moved from free to full sticker in a single visit, and — worst of all — when you check your plan portal, your deductible has barely moved despite the manufacturer paying thousands on your behalf. Welcome to a copay accumulator.

A copay accumulator is a plan design that accepts manufacturer copay assistance at the pharmacy counter but refuses to credit the manufacturer's dollars to your deductible or annual out-of-pocket maximum. A copay maximizer is the more sophisticated cousin: it sets your copay for that drug to match the manufacturer's annual coupon cap divided across twelve months, so you never see the shocking bill — but the manufacturer's money still never reaches your deductible. Both mechanics accomplish the same result for the plan: the insurer keeps the coupon dollars, your out-of-pocket clock keeps ticking, and you pay more.

As of January 2026, twenty-six states plus the District of Columbia and Puerto Rico have passed "all copays count" laws that outlaw accumulators for state-regulated (fully insured) plans. But those laws don't reach the roughly 65% of workers on self-funded ERISA plans, and many state statutes don't reach maximizer designs or alternative funding programs at all. Federal rulemaking is finally coming — the CMS Notice of Benefit and Payment Parameters for 2027 is expected to require ACA marketplace plans to credit manufacturer assistance for drugs without a medically appropriate generic — but for now, whether your coupon actually helps you depends on where you live, who runs your plan, and which mechanic your plan uses. Here is the 2026 field guide.

The insurance and pharmacy benefit manager (PBM) industry has invented multiple designs to intercept manufacturer coupon dollars. They look different at the pharmacy counter but are economically similar.

The tells are subtle and often buried. Your Summary Plan Description will describe the mechanic — look for phrases like "variable copay," "true accumulator," "coupon adjustment program," "specialty savings program," "SaveonSP," "PayerMatrix," "PillarRx," or "ClearScript." An alternative funding program almost always uses branded vendor language.

Not every accumulator ban applies to every plan. The regulator that governs your plan determines which law protects you.

Fully insured plans in one of the 26 states

If your plan is fully insured (the insurance company bears the risk and pays claims from premiums) and you live in Arizona, Arkansas, Colorado, Connecticut, Delaware, Georgia, Illinois, Indiana, Kentucky, Louisiana, Maine, Maryland, Minnesota, New Jersey, New Mexico, New York, North Carolina, Oklahoma, Oregon, Rhode Island, Tennessee, Texas, Vermont, Virginia, Washington, West Virginia, DC, or Puerto Rico — most state laws require the insurer to credit manufacturer assistance toward your deductible and out-of-pocket max. Scope varies: some laws apply only to drugs without a generic equivalent; some are specialty-drug specific. Check your state's statute or your state Department of Insurance FAQ.

Self-funded ERISA plans (about 65% of employer coverage)

If your employer self-funds (the employer bears the claims risk and uses the insurance company only as a third-party administrator), ERISA preempts state insurance law. No state ban reaches you regardless of geography. Only a federal fix — either an HHS rule that explicitly covers group health plans, or an act of Congress like the HELP Copays Act — would change that. Neither has happened as of August 2026.

ACA marketplace plans (individual and small group)

For 2026, marketplace carriers can still use accumulator designs. Starting with plan year 2027, HHS is expected to require ACA marketplace plans to count manufacturer copay assistance toward the annual out-of-pocket maximum for prescription drugs without a medically appropriate generic alternative, based on the 2023 federal court ruling that vacated the Trump-era Notice of Benefit and Payment Parameters permission for accumulators. Some carriers have already conformed voluntarily for 2026.

Medicare Part D

The accumulator/maximizer fight is essentially a commercial-insurance fight. Manufacturer copay coupons are generally not permitted under the federal anti-kickback statute for Medicare beneficiaries; the alternatives are the Extra Help / Low Income Subsidy program, HHS-approved independent charity foundations, and the 2026 $2,100 Part D out-of-pocket cap combined with the Medicare Prescription Payment Plan (M3P). If you're on Medicare, focus on those tools rather than manufacturer coupons.

Fill your first prescription of the plan year using the manufacturer coupon. Within seven to ten days, three numbers on your plan portal or Explanation of Benefits will tell you the design.

1. Total allowed amount — the negotiated price the plan owes at the counter (say, $2,400).
2. Member responsibility — what you personally paid (often $0 with a coupon).
3. Deductible/OOP credit — how much of the $2,400 was added to your running totals.

Then compare:

• Traditional design. Deductible credit ≈ total allowed amount. Your coupon is being credited.
• Accumulator. Deductible credit ≈ member responsibility only (typically $0 or a token amount). The coupon dollars are being pocketed by the plan.
• Maximizer. Member responsibility is not zero — it looks like a normal copay of, say, $150 to $500 — but the drug is priced identically every month for 12 months and never leads to hitting your deductible. That's the fingerprint.
• Alternative funding program. The drug simply isn't on your plan's formulary; a vendor calls you and asks you to enroll in a program to get the drug. No claim runs through your health plan at all.

Screenshot the EOB, the deductible tracker, and the pharmacy receipt. These documents are your evidence if you need to file a state complaint, an internal appeal, or an external review.

Step 1: Confirm the mechanic and the plan type

Call the number on the back of your insurance card and ask two specific questions: "Does my plan use a copay accumulator, copay maximizer, or variable copay program for this drug?" and "Is my plan fully insured or self-funded?" Ask them to email or mail the answer in writing. Simultaneously, ask HR the same self-funded/fully-insured question. If the two answers disagree, HR is authoritative — the employer knows how it funds claims.

Step 2: Apply the right rule

Match the plan type to the applicable rule:

• Fully insured plan in an "all copays count" state → file a written request for retroactive crediting citing the state statute. If the insurer refuses, file a complaint with your state Department of Insurance. State DOIs typically respond within 30–60 days and can order corrective action.
• ACA marketplace plan in 2026 → check the plan's Summary of Benefits; if it explicitly credits manufacturer assistance, request retroactive correction. If not, note the plan year — the CMS 2027 rule may require credit next year and inform your open-enrollment shopping.
• Self-funded ERISA plan → skip to Step 3. State law doesn't reach you.
• Medicare Part D → manufacturer coupons don't apply; use Extra Help, M3P, and independent foundations instead.

Step 3: Route around the accumulator with real financial assistance

If the plan-side fight is a dead end, replace the coupon with a program the plan cannot intercept:

• Manufacturer Patient Assistance Programs (PAPs). Every major specialty manufacturer runs a PAP separate from the coupon program. PAPs typically require an income test (often 400% to 600% of federal poverty) and provide the drug free directly, bypassing the pharmacy claim entirely. Find the PAP at needymeds.org or on the manufacturer's website.
• Independent charitable foundations. The PAN Foundation, HealthWell Foundation, Good Days, The Assistance Fund, and NORD run diagnosis-specific funds. These funds open and close as they are refilled; sign up for waitlist alerts because funds can reopen mid-year with 24-hour notice.
• Formulary exception to a lower-tier alternative. Ask your prescriber whether a therapeutically equivalent drug is on a lower tier or a lower-cost biosimilar exists. Even a marginal switch can move you out of accumulator territory.
• Direct patient pricing. For some drugs (especially generics and older brands), cash pricing through a discount card or a direct-from-manufacturer program is cheaper than running through your plan. This does not build deductible either, but it costs less month-to-month.

Step 4: At open enrollment, choose a plan design that credits assistance

Open enrollment for 2027 begins November 1, 2026 for the marketplace and typically in October or November for employer plans. If your current plan uses an accumulator or maximizer and you have any choice, use the following filter — in order of preference:

1. A plan whose Summary of Benefits explicitly says "manufacturer copay assistance applies to the deductible and out-of-pocket maximum."
2. A fully insured plan in an "all copays count" state.
3. A 2027 ACA marketplace plan (which will be covered by the pending federal rule for drugs without a generic).
4. A high-deductible health plan paired with an HSA if the manufacturer coupon is not usable anyway — HSA tax savings can offset the loss of coupon credit.

Always compute total annual out-of-pocket at your expected drug and medical usage before switching. A plan with a slightly higher premium that credits coupons is usually cheaper for a specialty-drug patient than a low-premium plan that runs an accumulator.

Two federal efforts are on the table.

The HELP Copays Act

Reintroduced by a bipartisan group of House members, the Help Ensure Lower Patient (HELP) Copays Act would require all group and individual health plans — fully insured and self-funded — to count third-party copay assistance (manufacturer, nonprofit, or charitable foundation) toward the deductible and out-of-pocket maximum. It would also codify that price concessions from drug manufacturers do not count as "cost sharing" for purposes of the ACA's definition. As of August 2026 the bill has not been enacted; it needs Senate momentum to advance.

CMS Notice of Benefit and Payment Parameters (NBPP) 2027

Following a 2023 federal court ruling that vacated the previous NBPP's permission for accumulators, CMS has signaled it will address accumulators and maximizers in the 2027 rule for ACA marketplace plans. The 2026 NBPP notably did not fix this, disappointing patient groups. The 2027 rule is expected to require marketplace plans to count manufacturer assistance toward the OOP max for drugs without a medically appropriate generic alternative — but will not automatically reach employer group plans.

• Retroactive discovery. Many people first learn their plan uses an accumulator when the coupon runs out mid-year and the pharmacy hands them a five-figure bill. Check your first claim in January — don't wait.
• The "$0 copay" illusion at the counter. A $0 receipt from a coupon does not mean the plan credited $2,400 to your deductible. Verify on the portal.
• Maximizer designs often escape state bans. Many "all copays count" laws explicitly address accumulators but leave maximizer designs unaddressed because the patient never sees a spike. Read your state statute carefully; some 2025 and 2026 amendments have closed this loophole.
• Alternative funding programs and citizenship. Some AFPs source drugs from abroad or from limited-eligibility patient assistance programs — check whether you're eligible before the plan year starts.
• Losing charitable foundation eligibility. If you have "any other insurance that covers the drug" — including coverage that would cover it but for the accumulator — some foundations disqualify you. Read foundation eligibility rules carefully.
• Copay card terms are annual. A card that gave you $18,000 in 2026 may have a $12,000 cap in 2027 — or a per-fill cap that limits how quickly you can burn through it. Re-enroll in the card each January.
• Prior authorization plus accumulator. If the drug also requires prior authorization, an accumulator on top can be a two-front war. Fight the PA first, then verify crediting; a denied PA means the coupon can't run at all.

Choosing between a plan that credits coupons and one that doesn't is fundamentally an out-of-pocket math problem. Three free calculators help:

• Price your specialty drug at your current pharmacy — and at nearby preferred pharmacies — with the Drug Cost Finder to see the annual retail exposure if the coupon runs out mid-year.
• Model total annual cost under a plan that credits the coupon versus one that doesn't with the Plan Cost Calculator. Enter the premium, deductible, expected drug spend, and expected medical services under each plan design.
• Use the Deductible Explainer to understand how coinsurance, copays, and out-of-pocket maximum interact once the accumulator is factored in.
• If you're comparing an HDHP+HSA against a traditional plan to work around a stubborn accumulator, run the tax math with the HSA vs FSA Calculator.
• If you get subsidies through the marketplace, confirm your 2027 subsidy exposure with the ACA Subsidy Calculator before you choose the plan.

In 2026, whether your manufacturer copay card actually helps depends on three things: whether your plan uses an accumulator or maximizer design, whether your plan is fully insured (state law reaches it) or self-funded (state law does not), and whether you're on a marketplace plan that will be swept into the pending CMS 2027 rule. Twenty-six states plus DC and Puerto Rico now protect fully insured members. Roughly 65% of employer-plan members are self-funded and are on their own until Congress passes the HELP Copays Act or HHS extends federal protection to group plans.

The workflow is the same regardless of plan: verify the mechanic on your first EOB in January, invoke your state law if one applies, and — if it doesn't — route around the accumulator with a manufacturer PAP, a diagnosis-specific charitable foundation, a formulary exception, or a plan choice at the next open enrollment that credits the coupon. Do not wait for the manufacturer coupon to run out and the pharmacy to hand you a five-figure bill. Verify in January, calculate the annual exposure now, and pick your 2027 plan with the coupon question already answered.